EXELIXIS INC. - US30161Q1040 (Aktie)
London
| Kurs | Diff.% | Datum & Zeit | Bid Volumen | Bid | Ask | Ask Volumen |
|---|---|---|---|---|---|---|
34,3167 USD
|
-5,1501% | 19.02.2025 16:19 | - | - | - | - |
| Kontakt | |
|---|---|
|
|
Exelixis Inc. 210 East Grand Avenue P.O. Box 94083-0511, San Francisco, CA, US |
| Telefon | |
| Fax | |
| Internet | http://www.exelixis.com |
| IR Kontakt/PR Kontakt | -/- |
| Symbol | |
| Ende des Geschäftsjahres | 29.12.2025 |
| Marktkapitalisierung | 13.434.289.756,40 EUR |
| Anteilseigner |
|---|
| Vorstand | |
|---|---|
| Dr. Stelios Papadopoulos | Chairman of Board of Directors |
| Dr. George Poste | Member of Board of Directors |
| Dr. Maria Freire | Member of Board of Directors |
| Dr. Mary Beckerle | Member of Board of Directors |
| Dr. S. Eckhardt | Member of Board of Directors |
| Jack Wyszomierski | Member of Board of Directors |
| Jacqueline Wright | Member of Board of Directors |
| Julie Smith | Member of Board of Directors |
| Robert Oliver | Member of Board of Directors |
| Tomas Jan Heyman | Member of Board of Directors |
| Dr. Alan Garber | Member of Board of Directors |
| David Johnson | Member of Board of Directors |
| Unternehmensprofil |
|---|
| - |
© 2000 - 2025 UniCredit Bank Austria AG. Bitte beachten Sie die Nutzungsbedingungen
Daten und Kursinformationen von FactSet
Fondsdaten von Mountain-View Data Gmbh
Austria-HomePage Version 2.0.54
